JP2024515936A5 - - Google Patents
Info
- Publication number
- JP2024515936A5 JP2024515936A5 JP2023556950A JP2023556950A JP2024515936A5 JP 2024515936 A5 JP2024515936 A5 JP 2024515936A5 JP 2023556950 A JP2023556950 A JP 2023556950A JP 2023556950 A JP2023556950 A JP 2023556950A JP 2024515936 A5 JP2024515936 A5 JP 2024515936A5
- Authority
- JP
- Japan
- Prior art keywords
- ribonucleic acid
- guide
- sequence
- manipulated
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163510P | 2021-03-19 | 2021-03-19 | |
| US63/163,510 | 2021-03-19 | ||
| US202163186506P | 2021-05-10 | 2021-05-10 | |
| US63/186,506 | 2021-05-10 | ||
| US202163241916P | 2021-09-08 | 2021-09-08 | |
| US63/241,916 | 2021-09-08 | ||
| PCT/US2022/021004 WO2022198080A1 (en) | 2021-03-19 | 2022-03-18 | Multiplex editing with cas enzymes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515936A JP2024515936A (ja) | 2024-04-11 |
| JP2024515936A5 true JP2024515936A5 (https=) | 2025-03-25 |
Family
ID=83321225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556950A Pending JP2024515936A (ja) | 2021-03-19 | 2022-03-18 | Ｃａｓ酵素を用いたマルチプレックス編集 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250075233A1 (https=) |
| EP (1) | EP4308699A4 (https=) |
| JP (1) | JP2024515936A (https=) |
| KR (1) | KR20230157387A (https=) |
| AU (1) | AU2022237663A1 (https=) |
| BR (1) | BR112023018948A2 (https=) |
| CA (1) | CA3210361A1 (https=) |
| MX (1) | MX2023010969A (https=) |
| WO (1) | WO2022198080A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178933A2 (en) | 2020-03-06 | 2021-09-10 | Metagenomi Ip Technologies, Llc | Class ii, type v crispr systems |
| WO2021226363A1 (en) * | 2020-05-08 | 2021-11-11 | Metagenomi Ip Technologies, Llc | Enzymes with ruvc domains |
| CA3205865A1 (en) * | 2021-01-22 | 2022-07-28 | Brian C. Thomas | Novel engineered and chimeric nucleases |
| AU2022335499A1 (en) | 2021-08-27 | 2024-02-22 | Metagenomi Therapeutics, Inc. | Enzymes with ruvc domains |
| AU2022396533A1 (en) | 2021-11-24 | 2024-05-02 | Metagenomi Therapeutics, Inc. | Endonuclease systems |
| WO2024127370A1 (en) * | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target trac gene and methods of use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003099215A2 (en) * | 2002-05-20 | 2003-12-04 | Pharmacia Corporation | Antisense modulation of glucocorticoid receptor expression |
| US20150017136A1 (en) * | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| CA2985650A1 (en) * | 2015-05-13 | 2016-11-17 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Enhancing endonuclease based gene editing in primary cells |
| EP3423580A1 (en) * | 2016-03-04 | 2019-01-09 | Editas Medicine, Inc. | Crispr-cpf1-related methods, compositions and components for cancer immunotherapy |
| MX2019013514A (es) * | 2017-05-12 | 2020-01-20 | Crispr Therapeutics Ag | Materiales y metodos para modificar celulas por ingenieria genetica y usos de los mismos en inmunooncologia. |
| EP3686275A4 (en) * | 2017-09-18 | 2021-09-29 | Edigene Inc. | GENE EDITING LYMPHOCYTE T AND RELATED USE |
| EP3746554A1 (en) * | 2018-01-30 | 2020-12-09 | Editas Medicine, Inc. | Systems and methods for modulating chromosomal rearrangements |
| US12275951B2 (en) * | 2018-02-06 | 2025-04-15 | Ohio State Innovation Foundation | Engineered guide RNA and uses thereof |
| CA3089587A1 (en) * | 2018-02-08 | 2019-08-15 | Sangamo Therapeutics, Inc. | Engineered target specific nucleases |
| CA3241703C (en) * | 2019-02-14 | 2026-02-24 | Metagenomi Therapeutics, Inc. | Enzymes with ruvc domains |
| US10913941B2 (en) * | 2019-02-14 | 2021-02-09 | Metagenomi Ip Technologies, Llc | Enzymes with RuvC domains |
| CN113825834A (zh) * | 2019-03-11 | 2021-12-21 | 索伦托药业有限公司 | 使用rna引导的核酸内切酶进行dna构建体整合的改进工艺 |
| GB201907733D0 (en) * | 2019-05-31 | 2019-07-17 | Governing Council Of The Univ Of Toronto | Methods and compositions for multiplex gene editing |
-
2022
- 2022-03-18 JP JP2023556950A patent/JP2024515936A/ja active Pending
- 2022-03-18 KR KR1020237034371A patent/KR20230157387A/ko active Pending
- 2022-03-18 BR BR112023018948A patent/BR112023018948A2/pt active Search and Examination
- 2022-03-18 EP EP22772310.3A patent/EP4308699A4/en active Pending
- 2022-03-18 MX MX2023010969A patent/MX2023010969A/es unknown
- 2022-03-18 AU AU2022237663A patent/AU2022237663A1/en active Pending
- 2022-03-18 CA CA3210361A patent/CA3210361A1/en active Pending
- 2022-03-18 WO PCT/US2022/021004 patent/WO2022198080A1/en not_active Ceased
-
2023
- 2023-09-01 US US18/459,729 patent/US20250075233A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515936A5 (https=) | ||
| JP2025120176A5 (https=) | ||
| JP2023533417A5 (https=) | ||
| EP2248914A1 (en) | The use of class IIB restriction endonucleases in 2nd generation sequencing applications | |
| Pascale et al. | Amplification of an ancestral mammalian L1 family of long interspersed repeated DNA occurred just before the murine radiation. | |
| Gotoh et al. | Locations of frequently opening regions on natural DNAs and their relation to functional loci | |
| JPH07507201A (ja) | 可変鋳型反応 | |
| JPH04108385A (ja) | 均一化ｃＤＮＡライブラリーの作製法 | |
| Simmons et al. | Five novel genes from the cri-du-chat critical region isolated by direct selection | |
| MXPA04008373A (es) | Metodo para reduccion de errores en poblaciones de acido nucleico. | |
| US20200299764A1 (en) | System and method for transposase-mediated amplicon sequencing | |
| JP2024541811A5 (https=) | ||
| JP2022533366A (ja) | プライマー認識が改良されたＰｈｉ２９ ＤＮＡポリメラーゼ変異体 | |
| WO2023230552A2 (en) | Preparation of long read nucleic acid libraries | |
| Rougeon et al. | Cloning and amplification of rabbit alpha-and beta-globin gene sequences into Escherichia coli plasmids. | |
| EP1253205A1 (en) | Method of blocking amplification of selected sequences | |
| US20180346963A1 (en) | Preparation of Concatenated Polynucleotides | |
| CN118360314A (zh) | 紫花苜蓿CRISPR/Cas9多靶点编辑系统及其应用 | |
| Barth et al. | Polycistronic transcription and editing of the mitochondrial small subunit (SSU) ribosomal RNA in Dictyostelium discoideum | |
| Bonavita et al. | The evolutionary conservation of rps3 introns and rps19-rps3-rpl16 gene cluster in Adiantum capillus-veneris mitochondria | |
| Winkfein et al. | A new family of repetitive, retroposon‐like sequences in the genome of the rainbow trout | |
| Furuya et al. | Natural evolution of coronavirus defective-interfering RNA involves RNA recombination | |
| US20220259632A1 (en) | Method of oligonucleotide synthesis | |
| WO2023183627A1 (en) | Production of reverse transcribed dna (rt-dna) using a retron reverse transcriptase from exogenous rna | |
| JP2024534639A5 (https=) |